Gastro Medical News about Pancreatic Neoplasms

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Use of Antiemetic Agents in Acute Gastroenteritis

3. 2008 Exclusive Survey—Earnings: Good news for primary care income

4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity

5. Medicare pay-for-reporting effort draws fire from frustrated doctors

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

A phase I study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancer
Cancer Chemotherapy and Pharmacology, 10/29/09

Cohen SJ et al. – The recommended phase II dose of imexon is 875 mg/m^2 with gemcitabine 1,000 mg/m^2. DLT was acute abdominal pain and cramping. Encouraging antitumor responses support further evaluation of this combination in advanced pancreatic cancer.

<< Previous
Alcohol Stimulates Activation of Snail, Epidermal Growth Factor...

Next >>
Hemodynamic failure as an indication to urgent liver...

Today in Biliary System/Pancreas...keeping you current

Novel Pancreaticojejunostomy with a Low Rate of Anastomotic Failure-Related Complications
Journal of the American College of Surgeons, 10/30/09

Day case laparoscopic cholecystectomy is feasible
Irish Journal of Medical Science, 11/02/09

Gemcitabine, oxaliplatin and 5-FU in advanced bile duct and gallbladder carcinoma: two parallel, multicentre phase-II trials
British Journal of Cancer, 11/13/09

See All of Biliary System/Pancreas

Today in GI Oncology...keeping you current

Treatment of Fistulizing Inflammatory Bowel Disease
Gastroenterology Clinics of North America, 11/13/09

Safety Profile of IBD: Lymphoma Risks
Gastroenterology Clinics of North America, 11/16/09

Image-enhanced endoscopy in practice
Canadian Journal of Gastroenterology, 11/06/09

See All of GI Oncology

Today in Pharmacology/kinetics...keeping you current

Safety Profile of IBD: Lymphoma Risks
Gastroenterology Clinics of North America, 11/16/09

Methotrexate for maintenance of remission in Crohn's disease
Cochrane Reviews, 10/27/09

Monotherapy versus combination therapy for the treatment of chronic hepatitis B
Expert Opinion on Investigational Drugs, 10/26/09

See All of Pharmacology/kinetics

Sponsor

Article Search